Zoloft is an antidepressant classified as a selective serotonin re-uptake inhibitor (SSRI), and it is known generically as sertraline. The antidepressant medicine, Zoloft, was approved by the U.S. Food and Drug Administration in 1991. Doctors prescribe Zoloft to patients who are suffering from depression and anxiety disorders.
The use of an SSRI antidepressant, such as Zoloft, by pregnant women is known to result in the development of harmful and life-threatening birth defects in children. These congenital birth defects include, but are not limited to, the following:
These Zoloft-linked birth defects cause an unwarranted amount of suffering for a newborn child. The congenital heart defects such as atrial septal defects and ventricular septal defects are known as holes in the heart, and require surgery to fix. Omphalocele is a serious health condition in which the newborn child’s organs are formed on the exterior of the body, and exist in a thin sac.
Craniosynostosis is a malformation of the skull due to premature suture fusion. Due to the pressure placed on the brain, Craniosynostosis can lead to further issues including vision problems, sleeping complications, and mental retardation.
Persistent Pulmonary Hypertension of the Newborn (PPHN) is a health condition in which the blood flow in the newborn remains in a oxygen-less state, as it perpetually bypasses the lungs, leaving the newborn in a state of hypoxemia.
If your newborn has suffered an incredible amount of pain due to the development of a congenital birth defect from exposure to Zoloft, you may be eligible to receive recompense for your suffering, distress, and losses. For a free legal consultation about filing a Zoloft lawsuit, contact an experienced Zoloft birth defects lawyer at Carey Danis & Lowe today.
The FDA has categorized Zoloft as a Pregnancy C drug meaning that an increased risk for congenital birth defects when taken during pregnancy cannot be ruled out.
Common Zoloft birth defects include but are not limited to:
FDA Approval: December 30, 1991 for major depression, OCD & general anxiety in adults
Generic Availability: June 30, 2006
Pregnancy Risk: Category C